Skip navigation

Refine by Type

Results 1 - 10 of 36 for LENALIDOMIDE
  1. Lenalidomide is used to treat a certain type of myelodysplastic syndrome (a group of conditions in which ... and does not produce enough healthy blood cells). Lenalidomide is also used along with dexamethasone to treat ...
  2. Myeloma (Leukemia & Lymphoma Society) - PDF  
    ... other drugs is under study in clinical trials. Lenalidomide (Revlimid®). This drug¸ given by mouth, is a ... or in combination with dexamethasone { { The immunomodulatory agent lenalidomide (Revlimid) plus dexamethasone { { The proteasome inhibitor carfilzomib (Krypolis™) { { ...
  3. ... have antitumor effects in multiple myeloma. Thalidomide and lenalidomide Thalidomide and lenalidomide are drugs called angiogenesis inhibitors that prevent the ...
  4. Myelodysplastic Syndromes (PDQ): Treatment From the National Institutes of Health (National Cancer Institute)  
    ... may be given to fight infection . Drug therapy Lenalidomide Patients with myelodysplastic syndrome associated with an isolated ... red blood cell transfusions may be treated with lenalidomide . Lenalidomide is used to lessen the need for ...
  5. ... treatment with at least two other medications, including lenalidomide (Revlimid) and bortezomib (Velcade). Pomalidomide is in a ... and pharmacist if you are allergic to pomalidomide, lenalidomide, thalidomide, any other medications, or any of the ...
  6. ... renal disease in multiple myeloma Related Searches Bortezomib Lenalidomide Melphalan Melphalan prednisone thalidomide Multiple myeloma Patient information ...
  7. ... treat MDS. They are: ● Azacitidine (Vidaza®) ● Decitabine (Dacogen®) ● Lenalidomide (Revlimid®) Azacitidine (Vidaza®) Given Through an IV Azacitidine ... patients. Given by Injection Capsule Taken by Mouth Lenalidomide (Revlimid®) Lenalidomide is approved for treating lower-risk ...
  8. Facts 2013 (Leukemia & Lymphoma Society) - PDF  
    ... azacitidine (Vidaza®) and decitabine (Dacogen®); immunomodulators such as lenalidomide (Revlimid ® ), pomalidomide (Pomalyst ® ) and thalidomide (Thalomid®); monoclonal antibodies ...
  9. ... who received at least two prior therapies, including lenalidomide (Revlimid ® ) and bortezomib (Velcade ® ), and whose disease progressed ... despite at least two prior treatments of bortezomib, lenalidomide, or both. The primary endpoint of the open- ...
  10. ... to reduce the risk of blood clots. Thalidomide , lenalidomide , and pomalidomide are drugs that prevent blood vessels ... treated with: Erythropoietic growth factors . Prednisone . Danazol . Thalidomide , lenalidomide , or pomalidomide , with or without prednisone. Treatment of ...
previous · 1 · 2 · 3 · 4 · next